Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SarCaBon trial of saracatinib versus placebo for cancer-induced bone pain
ISRCTN60942134Phase 2Completed
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Start
- Feb 2014
- Modality
- Small Molecules
01
Overview
Phase 2, randomised trial in bone metastasis pain (CIBP), bone metastases and Nonhematologic neoplasms comparing Saracatinib with Placebo (2 arms). Started Feb 2014; status: completed.
02
Drugs
saracatinib
03
Conditions
bone metastasis pain (CIBP)bone metastasesNonhematologic neoplasms
Beyond the preview
Go deeper on ISRCTN60942134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN60942134.